Definium Therapeutics, Inc. DFTX

Set alert

Price alert · DFTX

All alert types
33.33 USD +0.86 +2.65%

As of Nov 3, 3:00 PM ET

Bid
33.31 × 4
Ask
33.35 × 1
32.73 Day range 34.62
10.47 52-week range 49.70
YTD
+148.92%
1 year
+171.20%
Open
32.99
Prev close
32.47
Mkt cap
4.48B
Vol
1.06M
Avg vol
2.18M
EPS
-3.43
P/E
0.00
Div yield
0.00%
More statistics
Low
32.73
High
34.62
Forward P/E
-16.73
Beta
2.21
Short ratio
4.32
Inst. own
96.39%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
37.77
200-d avg
29.60
1y target
72.56

15m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (37)
NameTimeAgo
SMA: BearishNov 3, 1:40 PM1 hour ago
SMA: BullishNov 3, 1:10 PM1 hour ago
SMA: BearishNov 3, 11:40 AM3 hours ago
SMA: BullishNov 3, 9:40 AM5 hours ago
SMA: BullishNov 3, 9:40 AM5 hours ago
SMA: BearishNov 2, 3:10 PM23 hours ago
SMA: BullishNov 2, 2:55 PM1 day ago
MACD: Buy SignalNov 2, 2:55 PM1 day ago
RSI: OversoldNov 2, 2:25 PM1 day ago
MACD: Sell SignalNov 2, 10:40 AM1 day ago
RSI: OversoldNov 2, 10:40 AM1 day ago
SMA: BearishNov 2, 10:10 AM1 day ago
SMA: BullishNov 2, 9:55 AM1 day ago
SMA: BearishNov 2, 9:40 AM1 day ago
SMA: BullishOct 30, 3:25 PM4 days ago
RSI: OversoldOct 30, 2:55 PM4 days ago
MACD: Buy SignalOct 30, 2:40 PM4 days ago
RSI: OversoldOct 30, 2:10 PM4 days ago
RSI: OversoldOct 30, 12:10 PM4 days ago
RSI: OversoldOct 30, 9:40 AM4 days ago

Newest 20 of 37.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 72.56 +117.7% upside
Target (low)
55.00
Target (mean)
72.56
Target (high)
91.00
Ratings (0m) 19 19 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy14
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 19
  • 1 month ago 18
  • 2 months ago 18

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DFTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.56065-0.70 – -0.45-0.78+28.1%00.0%14
Next quarter-0.53494-0.74 – -0.42-0.50-7.0%00.0%14
Current year-3.19-3.59 – -2.93-2.06-54.7%00.0%15
Next year-1.94-4.16 – 0.05-3.19+39.1%29.32M0.0%14

Upgrades and downgrades

The latest rating changes

DFTX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026JP MorganInitiated—Overweight
Sep 15, 2026Canaccord GenuityMaintainedBuyBuy
Sep 15, 2026BairdMaintainedOutperformOutperform
Sep 14, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 14, 2026NeedhamReiteratedBuyBuy
Sep 11, 2026RBC CapitalReiteratedOutperformOutperform
Aug 18, 2026B of A SecuritiesInitiated—Buy
Aug 14, 2026Maxim GroupMaintainedBuyBuy
Aug 13, 2026Jones TradingMaintainedBuyBuy
Aug 13, 2026Canaccord GenuityMaintainedBuyBuy
Aug 13, 2026RBC CapitalMaintainedOutperformOutperform
Aug 13, 2026Wells FargoMaintainedOverweightOverweight
Aug 13, 2026BairdMaintainedOutperformOutperform
Aug 12, 2026NeedhamMaintainedBuyBuy
Aug 7, 2026Piper SandlerReiteratedOverweightOverweight
Jul 27, 2026Wells FargoInitiated—Overweight
Jul 24, 2026Piper SandlerReiteratedOverweightOverweight
Jul 8, 2026StifelMaintainedBuyBuy
Jun 30, 2026Canaccord GenuityMaintainedBuyBuy
Jun 24, 2026Jones TradingMaintainedBuyBuy
Jun 23, 2026BairdMaintainedOutperformOutperform
Jun 23, 2026NeedhamMaintainedBuyBuy
Jun 22, 2026Leerink PartnersMaintainedOutperformOutperform
Jun 22, 2026OppenheimerMaintainedOutperformOutperform
Jun 16, 2026Canaccord GenuityMaintainedBuyBuy
May 8, 2026Piper SandlerMaintainedOverweightOverweight
Apr 22, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 17, 2026StifelInitiated—Buy
Apr 16, 2026Canaccord GenuityMaintainedBuyBuy
Apr 10, 2026Piper SandlerInitiated—Overweight